Apertura Gene Therapy and the TSC Alliance Announce Collaboration to Advance Gene Therapy Programs Designed to Treat TSC
May 5, 2026 – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and the TSC Alliance, an internationally recognized nonprofit that improves quality of life for everyone affected by tuberous sclerosis complex (TSC), today announced…...